UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (85797) 85797
Newsletter (19504) 19504
Newspaper Article (3575) 3575
Book Chapter (218) 218
Transcript (195) 195
Magazine Article (189) 189
Dissertation (109) 109
Conference Proceeding (72) 72
Publication (69) 69
Trade Publication Article (25) 25
Book / eBook (20) 20
Book Review (17) 17
Streaming Video (12) 12
Web Resource (11) 11
Reference (10) 10
Government Document (2) 2
Journal / eJournal (1) 1
Poster (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lung cancer, non-small cell (58076) 58076
humans (51586) 51586
science & technology (48523) 48523
life sciences & biomedicine (46455) 46455
cancer (34347) 34347
oncology (32364) 32364
research (29759) 29759
female (28495) 28495
male (28419) 28419
lung neoplasms - pathology (24402) 24402
middle aged (24281) 24281
lung cancer (23695) 23695
aged (23388) 23388
carcinoma, non-small-cell lung - pathology (22268) 22268
care and treatment (21726) 21726
carcinoma, non-small-cell lung - drug therapy (18708) 18708
lung neoplasms - drug therapy (18333) 18333
oncology, experimental (17734) 17734
non-small cell lung cancer (16195) 16195
lung cancer, small cell (16181) 16181
adult (14701) 14701
prognosis (14443) 14443
chemotherapy (13135) 13135
carcinoma, non-small-cell lung - genetics (12066) 12066
lung neoplasms - genetics (11971) 11971
neoplasm staging (11242) 11242
analysis (9960) 9960
respiratory system (9878) 9878
metastasis (9842) 9842
aged, 80 and over (9767) 9767
lung neoplasms - mortality (9559) 9559
carcinoma, non-small-cell lung - mortality (9403) 9403
genetic aspects (9215) 9215
physical fitness (8973) 8973
tumors (8415) 8415
treatment outcome (8280) 8280
lung neoplasms - metabolism (8159) 8159
non-small cell lung carcinoma (8153) 8153
carcinoma, non-small-cell lung - metabolism (7995) 7995
lung neoplasms - surgery (7093) 7093
carcinoma, non-small-cell lung - surgery (7022) 7022
mutation (6975) 6975
health aspects (6800) 6800
antineoplastic combined chemotherapy protocols - therapeutic use (6783) 6783
cell line, tumor (6691) 6691
surgery (6451) 6451
retrospective studies (6377) 6377
apoptosis (5992) 5992
radiotherapy (5928) 5928
survival rate (5592) 5592
animals (5489) 5489
cancer therapies (5432) 5432
drug therapy (5412) 5412
development and progression (5341) 5341
antineoplastic agents - therapeutic use (5309) 5309
survival analysis (5290) 5290
hematology, oncology and palliative medicine (5233) 5233
epidermal growth factor (5177) 5177
patients (5144) 5144
clinical trials (5141) 5141
medical research (5013) 5013
carcinoma, non-small-cell lung - radiotherapy (4906) 4906
lung neoplasms - therapy (4897) 4897
carcinoma, non-small-cell lung - therapy (4869) 4869
lung neoplasms - radiotherapy (4750) 4750
nsclc (4519) 4519
non-small-cell lung cancer (4499) 4499
antineoplastic agents (4473) 4473
respiratory tract diseases (4459) 4459
abridged index medicus (4438) 4438
gene expression (4327) 4327
antimitotic agents (4279) 4279
immunohistochemistry (4230) 4230
immunotherapy (4197) 4197
lung neoplasms - diagnosis (4050) 4050
carcinoma, non-small-cell lung - diagnosis (3968) 3968
biochemistry (3967) 3967
patient outcomes (3940) 3940
medicine, experimental (3818) 3818
proteins (3630) 3630
mice (3621) 3621
medical prognosis (3611) 3611
universities and colleges (3591) 3591
pharmaceutical industry (3590) 3590
disease-free survival (3535) 3535
follow-up studies (3493) 3493
risk factors (3457) 3457
pharmacology & pharmacy (3365) 3365
diagnosis (3350) 3350
cell biology (3292) 3292
kinases (3265) 3265
carcinoma, non-small-cell lung - secondary (3174) 3174
gene expression regulation, neoplastic (3165) 3165
combined modality therapy (3154) 3154
medicine & public health (3089) 3089
lung neoplasms - diagnostic imaging (3074) 3074
radiology, nuclear medicine & medical imaging (3056) 3056
carcinoma, non-small-cell lung - diagnostic imaging (3045) 3045
adenocarcinoma - pathology (2981) 2981
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (105811) 105811
Chinese (1811) 1811
French (1192) 1192
Japanese (1174) 1174
German (555) 555
Spanish (256) 256
Polish (222) 222
Korean (211) 211
Russian (203) 203
Portuguese (146) 146
Italian (101) 101
Turkish (84) 84
Czech (57) 57
Hungarian (45) 45
Dutch (21) 21
Norwegian (18) 18
Bulgarian (16) 16
Serbian (15) 15
Danish (14) 14
Romanian (13) 13
Croatian (9) 9
Slovak (9) 9
Finnish (8) 8
Icelandic (8) 8
Lithuanian (7) 7
Hebrew (5) 5
Swedish (5) 5
Arabic (2) 2
Persian (2) 2
Belarusian (1) 1
Bosnian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 11/2014, Volume 371, Issue 21, pp. 1963 - 1971
Journal Article
PloS one, ISSN 1932-6203, 03/2013, Volume 8, Issue 3, pp. e60317 - e60317
.... However, its role in non-small cell lung cancer (NSCLC) has not been elucidated. The aim of this study was to investigate the contribution of miR-146a to various aspects of the malignant phenotype of human NSCLCs... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Lung Neoplasms - drug therapy | Humans | Lung Neoplasms - metabolism | Middle Aged | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Male | MicroRNAs - metabolism | NF-kappa B - metabolism | Antibodies, Monoclonal, Humanized - pharmacology | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacology | Lung - metabolism | Cetuximab | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung - pathology | ErbB Receptors - metabolism | Signal Transduction | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Lung - drug effects | Cell Line, Tumor | Aged | Cell Proliferation - drug effects | MicroRNAs - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | Apoptosis | Cell Movement | MicroRNA | Growth | Monoclonal antibodies | Lung cancer, Small cell | Development and progression | Lung cancer, Non-small cell | Health aspects | Cell proliferation | Laboratories | Lung cancer | Oncology | Drug delivery | Kinases | Paraffin | Cancer therapies | Metastases | Signal transduction | Cell growth | miRNA | Inhibition | Gefitinib | Sensitizing | NF-κB protein | Phenotypes | Cytokines | Epidermal growth factor receptors | Non-small cell lung carcinoma | siRNA | Breast cancer | Gene expression | Ribonucleic acid--RNA | Patients | Pathology | Signaling | Chemotherapy | Thyroid cancer | MicroRNAs | Medical prognosis | Pancreatic cancer | Biomarkers | Mutation | Cell migration | Cervical cancer | Tumors | Cancer | Index Medicus | RNA | Ribonucleic acid
Journal Article
The New England journal of medicine, ISSN 1533-4406, 08/2017, Volume 377, Issue 9, pp. 829 - 838
...–small-cell lung cancer. Importantly, it reduced the risk of CNS relapse. 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Central Nervous System Neoplasms - secondary | Young Adult | Pyridines - adverse effects | Anaplastic Lymphoma Kinase | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Pyrazoles - adverse effects | Pyridines - therapeutic use | Crizotinib | Carbazoles - adverse effects | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Animals | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Intention to Treat Analysis | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Central Nervous System Neoplasms - drug therapy | Drugs | Care and treatment | Analysis | Comparative analysis | Lung cancer, Non-small cell | Health aspects | Systemic diseases | Toxicity | Lung cancer | Central nervous system | Non-small cell lung carcinoma | Oncology | Nervous system | Metastasis | Radiation therapy | Patients | Lymphoma | Cancer therapies | Survival | Mutation | Protein-tyrosine kinase | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 05/2018, Volume 378, Issue 22, pp. 2078 - 2092
The addition of pembrolizumab to chemotherapy for metastatic lung cancer without EGFR or ALK mutations resulted in better progression-free and overall survival than chemotherapy alone... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Carcinoma, Non-Small-Cell Lung - secondary | Aged, 80 and over | Adult | Female | Lung Neoplasms - genetics | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Carcinoma, Non-Small-Cell Lung - genetics | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Antineoplastic Agents, Immunological - adverse effects | Antineoplastic Agents, Immunological - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Treatment outcome | Care and treatment | Chemotherapy | Usage | Analysis | Lung cancer, Non-small cell | Drug therapy | Cancer | Epidermal growth factor receptors | Laboratories | Lung cancer | Non-small cell lung carcinoma | Cytotoxicity | Metastasis | Patients | Cancer therapies | Metastases | Pembrolizumab | Hospitals | Platinum | PD-L1 protein | Response rates | Death | Mutation | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2018, Volume 379, Issue 21, pp. 2040 - 2051
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2018, Volume 378, Issue 2, pp. 113 - 125
In 556 patients with previously untreated lung cancer bearing EGFR mutations, osimertinib and the first-generation EGFR inhibitors erlotinib and gefitinib had similar response rates, but osimertinib... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | ErbB Receptors - genetics | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Gefitinib | Lung Neoplasms - genetics | Double-Blind Method | Carcinoma, Non-Small-Cell Lung - genetics | Kaplan-Meier Estimate | Survival Rate | Piperazines - therapeutic use | Carcinoma, Non-Small-Cell Lung - mortality | Piperazines - adverse effects | Disease-Free Survival | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Aged | Erlotinib Hydrochloride - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Protein-Tyrosine Kinases - antagonists & inhibitors | Treatment outcome | Cancer patients | Care and treatment | Lung cancer, Non-small cell | Analysis | Tyrosine | Medical research | Epidermal growth factor receptors | Lung cancer | Clinical trials | Non-small cell lung carcinoma | Oncology | Metastasis | Gene deletion | Patients | Cancer therapies | Clinical outcomes | Chemotherapy | Epidermal growth factor | Clonal deletion | Protein-tyrosine kinase receptors | Protein-tyrosine kinase | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article